article thumbnail

Top Specialties in Fellowship Programs and What They Offer: An In-depth Look for Medical Professionals

ADN Center of Excellence

Oncology Oncology fellowships are critical for those interested in addressing cancer, one of the most challenging and impactful diseases of our time. Fellows engage in diagnosing, treating, and researching cancers, gaining hands-on experience with cutting-edge treatments and therapies.

Cancer 59
article thumbnail

PO-06-020 TRANSVENOUS LEAD EXTRACTION AMONG PATIENTS WITH CANCER AND INFECTIVE ENDOCARDITIS

HeartRhythm

Furthermore the outcomes among patients with known cancer is not well documented. Transvenous lead extraction (TLE) is a revered procedure among Cardiologist.

Cancer 40
article thumbnail

STS Announces Late-breaker Research to Be Presented at the 2024 Annual Meeting

DAIC

The researchers found that Medicare patients undergoing esophagectomy for cancer exhibit identifiable predictors for long-term survival and readmission. These findings suggest opportunities to enhance clinical practice and improve outcomes for Medicare patients undergoing esophagectomy for cancer.

Research 111
article thumbnail

European Society of Cardiology Core Curriculum for cardio?oncology

European Journal of Heart Failure

Dealing with CV disease in patients with cancer requires special knowledge beyond that included in the general core curriculum for cardiology.

article thumbnail

Fellowship Programs Demystified: Why and When You Should Consider a Fellowship

ADN Center of Excellence

Oncology Oncology fellowships delve into cancer care, focusing on advancements in chemotherapy, immunotherapy, and targeted treatments. These programs prepare physicians to lead in the fight against cancer, both in clinical and research settings.

article thumbnail

PO-05-053 ALECTINIB INDUCED 3RD DEGREE ATRIOVENTRICULAR BLOCK

HeartRhythm

Alectinib is an anaplastic lymphoma kinase inhibitor used for treatment of non-small-cell lung cancer (NSCLC). Its cardiac side effects are well documented, with bradycardia being the most common [1].

article thumbnail

Dr. David Austin and Dr. C. Michael Gibson Discuss: Preventing Cardiac Damage In Patients Treated For Breast Cancer And Lymphoma: A Phase 3 Randomized, Open Label, Blinded Endpoint, Superiority Trial Of Enalapril To Prevent Anthracycline-induced Cardiotoxicity (PROACT)

Clinical Trial Results

Reload document | Open in new tab Download [1.85 Loading… Taking too long? MB] Disclosures: TBD